Human medicine European public assessment report (EPAR): Duloxetine Mylan

duloxetine, Neuralgia; Diabetic Neuropathies; Depressive Disorder, Major; Anxiety Disorders
Date of authorisation: 19/06/2015, , Revision: 17, Authorised, Last updated: 25/04/2022